Physician profile
Jan E Palmer
NPI 1225111040
$1,288.21
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,001 · 2020: $249 · 2021: $38.73.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $220.75 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $139.08 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $122.26 | 2019-2020 | |
| Abbvie INC. | $94.69 | 2019-2021 | |
| Amgen INC. | $84.45 | 2019-2020 | |
| Lilly USA, LLC | $82.62 | 2019-2020 | |
| Glaxosmithkline, LLC. | $76.39 | 2019-2020 | |
| Pfizer INC. | $69.74 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $59.57 | 2020 | |
| Abbott Laboratories | $59.26 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.94 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $43.11 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.93 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.70 | 2019 | |
| Sanofi-Aventis U.S. LLC | $37.66 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $28.05 | 2020 | |
| Allergan, INC. | $15.64 | 2020 | |
| Astellas Pharma US INC | $15.32 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.05 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.